Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.990
-0.120 (-2.92%)
At close: Sep 4, 2026, 4:00 PM EDT
4.020
+0.030 (0.75%)
After-hours: Sep 4, 2026, 7:41 PM EDT
Zentalis Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
106
Market Cap
377.74M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 67.43M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 132.69M |
| Century Therapeutics | 109.16M |
| Q32 Bio | 53.74M |
| X4 Pharmaceuticals | 15.85M |
| Opus Genetics | 9.86M |
| EyePoint | 2.79M |
| Palisade Bio | 500.00K |
| Lyell Immunopharma | 27.00K |
ZNTL News
- 4 days ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 22 days ago - Zentalis announecs common stock offering, no amount given - TheFly
- 24 days ago - Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering - GlobeNewsWire
- 24 days ago - Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 4 weeks ago - Zentalis price target raised to $5 from $4 at Morgan Stanley - TheFly
- 4 weeks ago - Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire